These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7393290)

  • 21. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
    Bruce AW; Mahan DE; Belville WD
    Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Series of test results in patients with prostatic cancer: clinical and analytical aspects of interpretation.
    Jørgensen PJ; Røhl H; Hørder M
    Scand J Clin Lab Invest Suppl; 1985; 179():43-9. PubMed ID: 3866308
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical application of immunoenzyme assay for prostatic acid phosphatase].
    Yoshida K; Sato S; Nishimura T; Akimoto M
    Hinyokika Kiyo; 1989 Oct; 35(10):1819-22. PubMed ID: 2692448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
    Zweig MH; Ihde DC
    Cancer Res; 1985 Aug; 45(8):3945-50. PubMed ID: 3893691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in acid phosphatase levels during various prostatic operations].
    Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
    Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
    Vihko P; Kontturi M; Lukkarinen O; Ervasti J; Vihko R
    Cancer; 1985 Jul; 56(1):173-7. PubMed ID: 4005787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New assays for prostatic acid phosphatase and alkaline phosphatase isoenzymes.
    Pontes JE
    Urology; 1981 Mar; 17(Suppl 3):38-9. PubMed ID: 7010753
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prostatic acid phosphatase measured by immunoenzyme assay].
    Fuse H; Zama S; Shimazaki J
    Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of 2 methods of determining prostatic acid phosphatase].
    Venturini M; Calafati P; De Grandi R; Pescatore D; Varaldo M; Natta G
    Arch Maragliano Patol Clin; 1980; 36():35-41. PubMed ID: 6178374
    [No Abstract]   [Full Text] [Related]  

  • 31. [Semeiological value of so-called prostatic tartrate-labile acid phosphatases. (Critical study of 500 medical records)].
    von Niederhäusern W; Tuchschmid D
    Ann Urol (Paris); 1970 Sep; 4(3):205-11. PubMed ID: 5472678
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radioimmunologic determination of prostatic acid phosphatase].
    Schweiger H; Höhn W; Rohr H; Brand K
    Internist (Berl); 1983 Jan; 24(1):51-4. PubMed ID: 6341281
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum prostatic acid phosphatase].
    Chen M; Gai M; Fishelovitz J; Hegesh E
    Harefuah; 1983 May; 104(9):378-80. PubMed ID: 6674043
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases].
    Guerin JL; Canal P; Douchez J; Soula G
    Bull Cancer; 1989; 76(10):1077-82. PubMed ID: 2635635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunoassay of prostatic acid phosphatase in carcinoma of the prostate.
    N Engl J Med; 1978 Apr; 298(16):912-3. PubMed ID: 634336
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F; Zambolin T; Bonora R; Panteghini M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of prostatic acid phosphatase assay as a tumor marker].
    Kuriyama M; Takahashi Y; Kawada Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():925-7. PubMed ID: 2355633
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acid phosphatase--interpretation of the test results].
    Ishibe T
    Nihon Rinsho; 1973; 31():1822-31. PubMed ID: 4582282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.